Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1988-01-14
1991-03-12
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
435215, 435226, 435212, C12N 972, A61K 37547
Patent
active
049991949
ABSTRACT:
A fibrin specific two-chain plasminogen activator in a therapeutic dosage form. A method is also provided for dissolving clots in vivo by application to the body of a fibrin specific two-chain plasminogen activator in therapeutic dosage form.
REFERENCES:
patent: 4766075 (1988-08-01), Goeddel et al.
Ichinose et al., J. Biol Chem., vol. 261, pp. 3486-3489, 1986.
Van Zonneveld et al., Proc. Natl. Acad. Sci., vol. 83, pp. 4670-4674, 1986.
Holmes, W. et al, Bio./Technology, vol. 3, pp. 923-929, 1985.
Rijken et al., J. Biol. Chem., vol. 256, pp. 7035-7041, 1981.
Lijnen, et al., Eur. J. Biochem., vol. 169, pp. 359-364, 1987.
Lijnen, et al., J. Biol. Chem., vol. 261, pp. 1253-1258, 1986.
Broeze Robert J.
Vovis Gerald F.
Collaborative Research, Inc.
Porta Marianne
Schwartz Richard A.
LandOfFree
Two-chain urokinase plasminogen activators for treatment of thro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Two-chain urokinase plasminogen activators for treatment of thro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Two-chain urokinase plasminogen activators for treatment of thro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-447679